drugset / Trial / NCT05259527

Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy

NCT05259527

Phase 2 Suspended 120 enrolled Virginia Commonwealth University
RandomizedParallel-groupSingle-blindSupportive care

Summary

This is a two-arm randomized clinical trial in which 80 participants with Vitamin D deficiency and scheduled to begin taxane-based chemotherapy will be randomized to either: 1) prescribed vitamin D replacement or 2) standard of care.

Timeline

Start
2022-12-19
Primary completion
2030-03-31
Completion
2030-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ergocalciferol Small molecule 50000 iu Oral

Indications